Epidemiology and Microbiology of Nosocomial Pediatric Candidemia at a Northern Indian Tertiary Care Hospital

Mycopathologia

Volumn 172, Issue 4, 2011, Pages 269-277

  Awasthi, Avijit Kumar ^a   Jain, Amita ^a   Awasthi, Shally ^a   Ambast, Ankur ^a   Singh, Kamlesh ^a   Mishra, Vijendra ^b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b BUNDELKHAND UNIVERSITY   (India)

Author keywords

Antifungal resistance; Candidemia; Colonization; Genetic relatedness; Nosocomial candidemia; Random amplification of polymorphic DNA

Indexed keywords

ANTIFUNGAL AGENT;

ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA; CANDIDEMIA; CHILD; CLASSIFICATION; DRUG EFFECT; FEMALE; HETEROZYGOTE; HOSPITAL; HUMAN; INDIA; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PRESCHOOL CHILD;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, FUNGAL; FEMALE; HOSPITALS; HUMANS; INDIA; INFANT; MALE; MICROBIAL SENSITIVITY TESTS;

CANDIDA; CANDIDA ALBICANS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; ISSATCHENKIA ORIENTALIS; KLUYVEROMYCES MARXIANUS;

EID: 80052439276     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9431-9     Document Type: Article

References (50)

1. Chang A, Neofytos D, Horn D. Candidemia in the 21st century. Futur Microbiol. 2008; 3(4): 463-72.
2. Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev. 1995; 8(4): 462-78.
3. Beck-Sague CM, Jarvis WR. The National Nosocomial Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis. 1993; 167(5): 1247-51.
4. Milne L J R. Fungi. In: Collee JG, Fraser AG, Marmion BP, et al. editors. Mackie and McCartney practical medical microbiology, 14th edn. London: Churchill Livingstone; 1996. p. 695-717.
5. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977; 296(23): 1305-9.
6. Warren MG, Roberts GD, Hazen KC: Candida, Cryptococcus, and other yeasts of medical importance In: Murry PR, Baron EJ, Pfaller MA, et al. editors. Manual of clinical microbiology, Sixth Edition. Washington, DC: ASM Press; 1995. p. 723-37.
7. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard 2nd edn. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002. Clinical and Laboratory Standards Institute document M27-A2.
8. Barry AL, Pfaller MA, Brown SD, Espinel-Ingroff A, et al. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J Clin Microbiol. 2000; 38(9): 3457-9.
9. Williams JKG, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res. 1990; 18(22): 6531-5.
10. Lehmann PF, Lin D, Lasker BA. Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J Clin Microbiol. 1992; 30(12): 3249-54.
11. Babay HA, Twum-Danso K, Kambal AM, Al-Otaibi FE. Bloodstream infections in pediatric patients. Saudi Med J. 2005; 26(10): 1555-61.
12. Viudes A, Pemán J, Cantón E, Ubeda P, López-Ribot JL, Gobernado M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis. 2002; 21(11): 767-74.
13. Neu N, Malik M, Lunding A, Whittier S, Alba L, Kubin C, Saiman L. Epidemiology of candidemia at a children's hospital, 2002 to 2006. Pediatr Infect Dis J. 2009; 28(9): 806-9.
14. MacDonald L, Baker C, Chenoweth C. Risk factors for candidemia in a children's hospital. Clin Infect Dis. 1998; 26(3): 642-5.
15. Singhi S, Rao DS, Raman V, Chakrabarti A. Candida colonization and candidemia in a pediatric intensive care unit. Pedia Crit Care Med. 2008; 9(1): 91-5.
16. Singh K, Chakrabarti A, Narang A, et al. Yeast colonization and fungemia in preterm neonates in a tertiary care center. Ind J Med Res. 1999; 110: 169-73.
17. Samonis G, Gikas A, Toloudis P, et al. Prospective study of the impact of broad spectrum antibiotics on the yeast flora of the human gut. Eur J Clin Microbiol Infect Dis. 1994; 13(8): 665-7.
18. Petri MG, Konig J, Moecke HP, et al. Epidemiology of invasive mycosis in ICU patients epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich society for chemotherapy, divisions of mycology and pneumonia research. Intensive Care Med. 1997; 23(3): 317-25.
19. Abelson JA, Moore T, Bruckner D, Deville J, Nielsen K. Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution. Pediatrics. 2005; 116(1): 61-7.
20. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994; 220(6): 751-8.
21. Almirante B, Rodríguez D, Cuenca-Estrella M, Almela M, Sanchez F, Ayats J, et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2006; 44(5): 1681-5.
22. Richet HM, Andremont A, Tancrede C, Pico JL, Jarvis WR. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis. 1991; 13(2): 211-5.
23. Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut? Clin Infect Dis. 2001; 33(12): 1959-67.
24. Charles PE, Dalle F, Aube H, Doise JM, Quenot JP, Aho LS, Chavanet P, Blettery B. Candida species colonization significance in critically ill medical patients: a prospective study. Intensive Care Med. 2005; 31(3): 393-400.
25. Martín E, Parras P, Lozano MC. In vitro Susceptibility of 245 Yeast Isolates to Amphotericin B, 5-Fluorocytosine, Ketoconazole, Fluconazole and Itraconazole. Chemotherapy. 1992; 38(5): 335-9.
26. Blyth CC, Chen SC, Slavin MA, Serena C, Nguyen Q, Marriott D, Ellis D, Meyer W, Sorrell TC. Australian Candidemia study. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics. 2009; 123(5): 1360-8.
27. Saha R, Shukla DD, Kumar A, Kaur IR. Pattern of Candida isolates in hospitalized children. Indian J Pediatr. 2008; 75(8): 858-60.
28. Agarwal J, Bansal S, Malik GK, Jain A. Trends in neonatal septicemia: emergence of non-albicansCandida. Indian Pediatr. 2004; 41(7): 712-5.
29. Jain A, Awasthi AK, Kumar M. Etiological and anti-microbial susceptibility profile of nosocomial blood stream infections (NBSI) in neonatal intensive care unit (NICU). Indian J Med Micro. 2007; 25(3): 299-300.
30. Price MF, Larocco MT, Gentrry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5 years period. Antimicro Agents Chemo. 1994; 38(6): 1422-4.
31. Zaoutis TE, Foraker E, McGowan KL, Mortensen J, Campos J, Walsh TJ, Klein JD. Antifungal susceptibility of Candida species isolated from pediatric patients: a survey of 4 children's hospitals. Diagn Microbiol Infect Dis. 2005; 52(4): 295-8.
32. Cuenca-Estrella M, Rodero L, García-Effrón G, Rodriguez-Tudela JL. Antifungal susceptibilities of Candida species isolated from blood in Spain and Argentina, 1996-1999. J Antimicrob Chemo. 2002; 49(6): 981-7.
33. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of Hematogenous Candidiasis caused by Candida species. Clin Infect Dis. 1997; 24(6): 1122-8.
34. Narain S, Shastri JS, Mathur M, Mehta PR. Neonatal systemic candidiasis in a tertiary care centre. Indian J Med Microbiol. 2003; 21(1): 56-8.
35. Narang A, Agarwal PR, Chakrabarti A, Kumar P. Epidemiology of systemic candidiasis in a tertiary care neonatal unit. J Trop Pedia. 1998; 44(2): 104-8.
36. Borg-von Zepelin M, Kunz L, Rüchel R, Reichard U, Weig M, Gross U. Epidemiology and antifungal susceptibilities of Candida species to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005. J Antimicrob Chemother. 2007; 60(2): 424-8.
37. Giusiano G, Mangiaterra M, Garcia Saito V, Rojas F, Gómez V, Díaz MC. Fluconazole and itraconazole resistance of yeasts isolated from the bloodstream and catheters of hospitalized pediatric patients. Chemotherapy. 2006; 52(5): 254-9.
38. Foongladda S, Sakulmaiwatana P, Petlum P, Vanprapar N. Candida species, genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999-2002. J Med Assoc Thai. 2004; 87(1): 92-9.
39. Hajjeh RA, Sofair AN, Harrison IH, Lyon GM, Arthington-Skaggs BA, Mirza SA, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol. 2004; 42(4): 1519-27.
40. Yang YL, Cheng HH, Lo HJ. Tsary hospitals. Distribution and antifungal susceptibility of Candida species isolated from different age populations in Taiwan. Med Mycol. 2006; 44(3): 237-42.
41. Hernández-Dueñas AM, Vázquez-Larios Mdel R, Soto-Nieto GI, Rivera-Martínez E. Yeast susceptibility isolated from blood cultures of patients at the National Cardiology Institute Ignacio Chávez. Rev Invest Clin. 2009; 61(4): 294-9.
42. González GM, Elizondo M, Ayala J. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-years (2004 to 2007) surveillance study. J Clin Microbiol. 2008; 46(9): 2902-5.
43. Espinel-Ingroff A. Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi. Rev Iberoam Micol. 2008; 25(2): 101-6.
44. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev. 1996; 9(4): 499-511.
45. Jordan JA. PCR identification of four medically important Candida species by using a single primer pair. J Clin Micro. 1994; 32(12): 2962-7.
46. Robert F, Lebreton F, Bougnoux ME, Paugam A, Wassermann D, Schlotterer M, et al. Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit. J Clin Microbiol. 1995; 33(9): 2366-71.
47. Roilides E, Farmaki E, Evdoridou J, Francesconi A, Kasai M, et al. Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol. 2003; 41(2): 735-41.
48. Pinto PM, Resende MA, Koga-Ito CY, Tendler M. Genetic variability analysis among clinical Candida species isolates using random amplified polymorphic DNA. Mem Inst Oswaldo Cruz. 2004; 99(2): 147-52.
49. Marol S, Yücesoy M. Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients. Mycoses. 2008; 51(1): 40-9.
50. Vrioni G, Matsiota-Bernard P. Molecular typing of Candida isolates from patients hospitalized in an intensive care unit. J Infect. 2001; 42(1): 50-6.